BY MARIUS AMBAKK BJORKEDAL
-
Johnson & Johnson invests USD 2bn in new factory
The financial investment is among numerous made by the firm as an outcome of Trump’s plan to bring making back to the United States.
-
CHMP recommends 13 new medicines for approval – makes use of rare exemption rule
The CHMP, which examines medication authorizations in the EU, suggests one medication under remarkable conditions.
-
Will German fiscal stimulus boost inflation much?
Will German fiscal stimulus increase inflation a lot?Read More
-
SEBI issues guidelines on internal audit mechanisms for market infra institutions
SEBI concerns standards on interior audit devices for market infra organizationsRead More
-
China becoming largest contributor to WHO: “Life goes on without the Americans”
At the yearly General Setting up of the Globe Health And Wellness Company, there was one main persisting style: Austerity.
-
AstraZeneca faces new potential million-dollar fine in China
AstraZeneca might be based on a penalty of approximately USD 8m for uncertainty of unsettled import tax obligations in China.
-
Analyst on Nykode’s change of course: More aggressive strategy than before
” It’s clear that it’s an extra hostile approach than the one they set out prior to Xmas,” claims DNB Markets elderly expert Geir Hiller Holom.
-
Bristol Myers Squibb appoints new CEO in the Nordics
Evris Michalopoulos, who comes from his position as Managing Director of Bristol Myers Squibb Finland, will now head your entire Nordic area.
-
Drugmakers seek product exemptions from tariff wars
” Interrupted supply chains might threaten people’ accessibility to life-saving medications,” states an elderly exec at a significant European pharmaceutical team…
-
EUR/USD Price Analysis: Neutral stance around 1.0930 as momentum stalls
EUR/USD traded continuously on Tuesday after the European session, floating around the 1.0930 location without clear instructions …Read More
